Articles Médicaux
Article 1
Developmental disorders of academic skills in children: the e‑cacy and safety of Tenoten for children in the multicenter double-blind placebo-controlled randomized study. Zavadenko N.N., Skripchenko N.V., Gaynetdinova D.D. et al. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova, 2020; 120(9): 28–36. DOI: 10.17116/jnevro202012009128
Article 2
Current possibilities in pharmacotherapy of anxiety disorders in children and adolescents. Zavadenko N.N., Simashkova N.V., Vakula I.N. S.S. Korsakov Journal of Neurology and Psychiatry. 2015;115(11): 33‑39. DOI: 10.17116/jnevro201511511133-39
Article 4
Effects of Tenoten on Anxiety and Depression Disorders in Patients with Epilepsy, A. B. Delger, G. N. Avakyan, O. M. Oleinikova. Bulletin of Experimental Biology and Medicine. September 2012; Vol. 153, No. 5, pp. 660-663
Article 5
The Use of Tenoten and Tenoten (Pediatric Formulation) as a Drug for Premedication in Adults and Children during Outpatients Dentist Visit. L. I. Larentsova, D. V. Lyubimova. Bulletin of Experimental Biology and Medicine, 2009; Vol. 148, Suppl. 1, pp. 88-90
Article 6
Open, randomized, comparative clinical study on the efficacy and safety of using Tenoten, 2 tablets 5 times a day for 4 weeks, for the cessation of reactive anxiety-depressive disorders and for the prophylaxis of post-traumatic stress disorder.
Open, randomized, comparative clinical study on the efficacy and safety of using Tenoten, 2 tablets 5 times a day for 4 weeks, for the cessation of reactive anxiety-depressive disorders and for the prophylaxis of post-traumatic stress disorder. Internal clinical study report TT1071111-101.C. OOO “NPF “MATERIA MEDICA HOLDING” Rusia, Moscú, 2008–2010. Confidential document
Article 8
Tenoten in the Therapy of Anxious Disturbances in Patients with Essential Hypertension and Coronary Heart Disease. N. P. Vanchakova and A. P. Popov, Bulletin of Experimental Biology and Medicine, 2009 ; Vol. 148, Suppl. 1, pp. 91-93
Article 9
Randomized, double-blind, placebo-controlled clinical study on the efficacy and safety of using Tenoten, 2 tablets 5 times a day for 4 weeks, in the treatment of anxiety in patients with neurological disorders
Randomized, double-blind, placebo-controlled clinical study on the efficacy and safety of using Tenoten, 2 tablets 5 times a day for 4 weeks, in the treatment of anxiety in patients with neurological disorders, . Internal clinical study report TT106152.1531-100.P OOO “NPF “MATERIA MEDICA HOLDING” Moscú, Rusia, 2009 – 2010. Confidential document.
